Knopman DS - Search Results

1

Mild cognitive impairment due to Alzheimer disease in the community.

Petersen RC, Aisen P, Boeve BF, Geda YE, Ivnik RJ, Knopman DS, Mielke M, Pankratz VS, Roberts R, Rocca WA, Weigand S, Weiner M, Wiste H, Jack CR Jr. Petersen RC, et al. Among authors: knopman ds. Ann Neurol. 2013 Aug;74(2):199-208. doi: 10.1002/ana.23931. Ann Neurol. 2013. PMID: 23686697 Free PMC article.

2

Alzheimer's disease: a comprehensive approach to patient management.

Bennett DA, Knopman DS. Bennett DA, et al. Among authors: knopman ds. Geriatrics. 1994 Aug;49(8):20-6. Geriatrics. 1994. PMID: 8039725 Review.

3

Observations on the short-term 'natural history' of probable Alzheimer's disease in a controlled clinical trial.

Knopman D, Gracon S. Knopman D, et al. Neurology. 1994 Feb;44(2):260-5. doi: 10.1212/wnl.44.2.260. Neurology. 1994. PMID: 8309570 Clinical Trial.

4

A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group.

Thal LJ, Schwartz G, Sano M, Weiner M, Knopman D, Harrell L, Bodenheimer S, Rossor M, Philpot M, Schor J, Goldberg A. Thal LJ, et al. Neurology. 1996 Dec;47(6):1389-95. doi: 10.1212/wnl.47.6.1389. Neurology. 1996. PMID: 8960716 Clinical Trial.

5

Cardiovascular risk factors and cognitive decline in middle-aged adults.

Knopman D, Boland LL, Mosley T, Howard G, Liao D, Szklo M, McGovern P, Folsom AR; Atherosclerosis Risk in Communities (ARIC) Study Investigators. Knopman D, et al. Neurology. 2001 Jan 9;56(1):42-8. doi: 10.1212/wnl.56.1.42. Neurology. 2001. PMID: 11148234

6

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, Small GW, Miller B, Stevens JC. Knopman DS, et al. Neurology. 2001 May 8;56(9):1143-53. doi: 10.1212/wnl.56.9.1143. Neurology. 2001. PMID: 11342678

7

Pharmacotheraphy for Alzheimer's disease.

Knopman D. Knopman D. Curr Neurol Neurosci Rep. 2001 Sep;1(5):428-34. doi: 10.1007/s11910-001-0102-y. Curr Neurol Neurosci Rep. 2001. PMID: 11898553 Review.

8

Incidence of vascular dementia in Rochester, Minn, 1985-1989.

Knopman DS, Rocca WA, Cha RH, Edland SD, Kokmen E. Knopman DS, et al. Arch Neurol. 2002 Oct;59(10):1605-10. doi: 10.1001/archneur.59.10.1605. Arch Neurol. 2002. PMID: 12374499

9

1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease.

Kantarci K, Smith GE, Ivnik RJ, Petersen RC, Boeve BF, Knopman DS, Tangalos EG, Jack CR Jr. Kantarci K, et al. Among authors: knopman ds. J Int Neuropsychol Soc. 2002 Nov;8(7):934-42. doi: 10.1017/s1355617702870084. J Int Neuropsychol Soc. 2002. PMID: 12405545 Free PMC article.

10

Survival study of vascular dementia in Rochester, Minnesota.

Knopman DS, Rocca WA, Cha RH, Edland SD, Kokmen E. Knopman DS, et al. Arch Neurol. 2003 Jan;60(1):85-90. doi: 10.1001/archneur.60.1.85. Arch Neurol. 2003. PMID: 12533093

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,130 results

Search Page

Filters